Free Trial

Harrow (HROW) Insider Trading & Ownership

Harrow logo
$42.82 +0.38 (+0.90%)
(As of 09:48 AM ET)

Harrow (NASDAQ:HROW) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.67%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$1.86 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get HROW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Harrow stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HROW Insider Buying and Selling by Quarter

Harrow Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/25/2024Opaleye Management Inc.Major ShareholderBuy20,000$9.97$199,400.00  
4/23/2024Opaleye Management Inc.Major ShareholderBuy11,715$10.29$120,547.35  
4/19/2024Opaleye Management Inc.Major ShareholderBuy29,400$10.56$310,464.00  
3/28/2024Opaleye Management Inc.Major ShareholderBuy50,000$12.82$641,000.00  
3/22/2024Mark L BaumCEOBuy9,000$11.59$104,310.00  
3/20/2024Opaleye Management Inc.Major ShareholderBuy50,600$9.65$488,290.00  
(Data available from 1/1/2013 forward)

HROW Insider Trading Activity - Frequently Asked Questions

The list of insiders at Harrow includes Andrew R Boll, Horn R Lawrence Van, Mark L Baum, Martin A Makary, Opaleye Management Inc., and Richard L Md Lindstrom. Learn more on insiders at HROW.

13.67% of Harrow stock is owned by insiders. Learn more on HROW's insider holdings.

The following insiders have purchased HROW shares in the last 24 months: Andrew R Boll ($33,850.00), Horn R Lawrence Van ($24,961.20), Mark L Baum ($598,775.00), Martin A Makary ($338,400.00), and Opaleye Management Inc. ($1,965,050.40).

Insiders have purchased a total of 247,392 HROW shares in the last 24 months for a total of $2,961,036.60 bought.

Harrow Key Executives

  • Mr. Mark L. Baum J.D. (Age 49)
    CEO & Chairman
    Compensation: $1.07M
  • Mr. Andrew R. Boll C.F.A. (Age 40)
    C.M.A., CFA, CMA, CFO & Corp. Sec.
    Compensation: $716.73k
  • Dr. Robert J. Kammer D.D.S. (Age 73)
    Special Advisor
    Compensation: $91.88k
  • Mr. John P. Saharek MBA (Age 62)
    Chief Commercial Officer
    Compensation: $621.92k
  • Jamie Webb
    Director of Communications & Investor Relations
  • Dr. Dennis E Saadeh Pharm.D.
    Chief of Formulation Strategy
  • Mr. Andrew Livingston
    Chief Innovation Officer
  • Ms. Kim Barratt
    Chief Talent Officer


This page (NASDAQ:HROW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners